Eight months after the second GKS treatment, MRI in July 2014 indicated that the tumor size was reduced slightly (Fig. 2G and H), and the serum prolactin levels decreased to 126.0 ng/mL (Supplemental Fig. 1). This evidence concerns the gene PRL and neoplasm.